Global GalNAc Transferases Market, By Type, Application & By Region - Forecast and Analysis 2022-2027

The GalNAc transferase market was valued at USD 10,877.70 Million in 2021, and it is expected to reach a value of USD 15,765.10 Million by 2027, at a CAGR of more than 6.38% over the forecast period (2022 - 2027). GalNAc transferase (GalNAc-T) family transfers an N-acetyl galactosamine to the hydroxyl group of a serine or threonine residue in the first step of O-linked oligosaccharide biosynthesis. Individual GalNAc-transferases have distinct activities and initiation of O-glycosylation is regulated by a repertoire of GalNAc-transferases. The protein encoded by this gene is highly homologous to other family members; however, the enzymes have different substrate specificities.



GalNAc Transferases are mainly divided into three types: Antibodies, Protein, Others. Antibodies are the most widespread type taking up more than 50% of the global market by 2021. North America is the largest consumption region of GalNAc Transferases in the world in the past few years and it will keep decreasing in the next few years. GalNAc Transferases industry market concentration is low, and the market competition is very intense. Although this market has shown a lot of opportunities, the research group still recommends that the new entrants with only an advantage in capital without sufficient support in technology and downstream channels not take the risk to enter this market.

The report provides market sizing and forecast across five major regions, namely, North America, Europe, Asia-Pacific (APAC), Latin America (LATAM), and Middle East & Africa (MEA). In this report, the year 2016 to 2020 is considered a historical year, 2021 is the base year, 2022 is the estimated year, and years from 2022 to 2027 are considered the forecast period.

Top-down and bottom-up approaches were used to estimate and validate the size of the global GalNAc Transferases market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares splits, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Aspects covered in this report

• Based on type, this market is segmented into antibodies, protein, and others.
• Based on application, this market is segmented into biopharmaceutical and research laboratories.
• Based on region, this market is categorized into North America, Europe, Asia-Pacific (APAC), Latin America (LATAM), and Middle East & Africa (MEA).

Players in this market adopted various strategies to expand their global footprint and augment their market share. The key strategies followed by most companies in the global GalNAc Transferases market were agreements and collaborations, mergers and acquisitions, and expansion.

The Major Key players that are present in the global gas mask market are Novus Biologicals, Abbexa, Antibodies-Online, Abnova, RayBiotech, USBio, R&D Systems, Thermo Fisher Scientific.